SCHEMBL27792012

SCHEMBL27792012

Cc1nc(Cl)cc(Nc2ncc(CC(=O)O)s2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 4/20 0.42
▸ ABL1 P00519 2/20 0.42
▸ JAK3 P52333 2/20 0.42
▸ KIT P10721 2/20 0.42
▸ MAPK13 O15264 1/20 0.42
▸ EGFR P00533 1/20 0.42
▸ ERBB2 P04626 1/20 0.42
▸ FYN P06241 1/20 0.42
▸ YES1 P07947 1/20 0.42
▸ LYN P07948 1/20 0.42
▸ HCK P08631 1/20 0.42
▸ FGR P09769 1/20 0.42
▸ BCR P11274 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ MAPK12 P53778 1/20 0.42
▸ MAPK11 Q15759 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ SIK2 Q9H0K1 3/20 0.41
▸ SIK3 Q9Y2K2 3/20 0.41
▸ SIK1 P57059 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27788420 0.85 LCK (0.42) LCKABL1JAK3KITMAPK13
SCHEMBL27788358 0.85 LCK (0.42) LCKABL1JAK3KITMAPK13
SCHEMBL28165662 0.85 ABL1 (0.41) LCKABL1JAK3KITMAPK13
SCHEMBL4254834 0.81 LCK (0.52) LCKABL1JAK3KITMAPK13
SCHEMBL17029102 0.79 CHRNA7 (0.38) LCKABL1JAK3KITMAPK13
SCHEMBL20633817 0.79 RAB9A (0.52) LCKABL1JAK3KITMAPK13
SCHEMBL12445981 0.79 LCK (0.52) LCKABL1JAK3KITMAPK13
SCHEMBL4254631 0.77 ABL1 (0.50) LCKABL1JAK3KITMAPK13
SCHEMBL22964566 0.77 LCK (0.56) LCKABL1JAK3KITMAPK13
SCHEMBL21495194 0.76 SIK2 (0.48) LCKABL1JAK3KITMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104910143-A Process and intermediates for the synthesis of dasatinib CERBIOS PHARMA SA 2015-09-16 — — CN disclosed
CN-101845045-A Novel method for synthesizing dasatinib NANJING CAVENDISH BIO ENGINEERING TECHNOLOGY CO LTD 2010-09-29 — — CN disclosed
Send feedback